Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons learned from the prospective pravastatin pooling project.

Robert P Byington1, Frank M Sacks

  • 1Department of Public Health Sciences, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1063, USA. bbyingto@wfubmc.edu

Current Atherosclerosis Reports
|August 7, 2004
PubMed
Summary

The Prospective Pravastatin Pooling (PPP) Project demonstrated pravastatin significantly reduces mortality and coronary events. This lipid-lowering drug proved safe across diverse patient groups in long-term trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effects of Sodium Reduction and the DASH Diet on Ambulatory Blood Pressure: Overall and Race-Stratified Results from the DASH-Sodium Trial.

American journal of hypertension·2026
Same author

Effects of Dietary Carbohydrate Amount and Glycemic Index on Blood Lipidomic Signatures and Diurnal Postprandial Glucose Responses: The OmniCarb Trial.

Diabetes·2026
Same author

Dietary intervention and cognition across Alzheimer's disease biomarker levels: The MIND clinical trial.

Journal of Alzheimer's disease : JAD·2026
Same author

Partially Replacing Dietary Carbohydrate With Unsaturated Fat or Protein Shifts Protein-Based HDL Subspecies Toward Lower Coronary Heart Disease Risk.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Effect modifiers of the MIND diet for cognition in older adults: The MIND diet trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Effect of weight loss through dietary interventions on cardiometabolic health in older adults.

International journal of obesity (2005)·2025

Area of Science:

  • Cardiovascular Medicine
  • Clinical Pharmacology

Background:

  • Lipid-lowering agents are crucial for cardiovascular disease prevention.
  • Pravastatin is a statin medication used to reduce cholesterol levels.
  • Previous trials suggested pravastatin's efficacy, but large-scale pooled data analysis was needed.

Purpose of the Study:

  • To pool data from multiple randomized trials of pravastatin.
  • To evaluate the long-term effects of pravastatin on mortality and coronary events.
  • To assess the safety profile of pravastatin in a large patient cohort.

Main Methods:

  • A pooled database of 19,768 participants from three randomized, placebo-controlled trials was created.
  • The Prospective Pravastatin Pooling (PPP) Project involved over 100,000 patient-years of follow-up.

Related Experiment Videos

  • Included primary and secondary prevention populations.

    • Main Results:

    • Pravastatin (40 mg/d) significantly reduced all-cause mortality.
    • Fatal and nonfatal coronary events were reduced by pravastatin treatment.
    • Stroke events were also significantly decreased in the pravastatin group.
    • The safety profile of pravastatin was confirmed across a broad range of patients.

    Conclusions:

    • Pravastatin is a safe and effective lipid-lowering agent for reducing cardiovascular events.
    • Pooled data analysis confirms pravastatin's benefit in both primary and secondary prevention.
    • Long-term pravastatin therapy offers significant advantages in cardiovascular risk reduction.